Search
GO-203-2C
go.drugbank.com/drugs/DB15008InvestigationalGO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Fulacimstat
go.drugbank.com/drugs/DB15085InvestigationalFulacimstat is under investigation in clinical trial NCT02452515 (A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With
Remtolumab
go.drugbank.com/drugs/DB15128InvestigationalRemtolumab is under investigation in clinical trial NCT02433340 (Phase 2, Multicenter, Open-Label Extension (OLE) Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12
ZR202-CoV
go.drugbank.com/drugs/DB27995InvestigationalZR202-CoV is a biologic drug. ZR202-CoV is under investigation in clinical trial NCT05490108 (Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.).
Quinolinic Acid
go.drugbank.com/drugs/DB01796ExperimentalA metabolite of tryptophan with a possible role in neurodegenerative disorders. … Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS. [PubChem]
SP-8203
go.drugbank.com/drugs/DB11670InvestigationalSP-8203 has been used in trials studying the treatment of Ischemic Stroke.
Melengestrol acetate
go.drugbank.com/drugs/DB14659ExperimentalA 6-methyl progesterone acetate with reported glucocorticoid activity and effect on estrus.
Preimplantation factor
go.drugbank.com/drugs/DB16301InvestigationalPreimplantation factor is under investigation in clinical trial NCT03593460 (Phase II Autoimmune Hepatitis).
ABT-737
go.drugbank.com/drugs/DB17023ExperimentalAn inhibitor of members of the Bcl‑2 family of apoptosis regulators.[A252977]
Synonyms: Benzamide, 4-(4-((4'-chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-n-((4-(((1r)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)-APR-548
go.drugbank.com/drugs/DB17546InvestigationalAPR-548 is an analog of [eprenetapopt] and a reactivator of mutant p53.